StageZero Life Sciences Announces Resignation of CFO

Author's Avatar
May 26, 2022

TORONTO, ON and RICHMOND, VA / ACCESSWIRE / May 26, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS, Financial) (OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced that Matthew Pietras has resigned as CFO and COO. Mr. Pietras will support the Company during the transition to a new CFO.